BIT
IMMU

BlackRock Institutional Trust’s Immunomedics Inc IMMU Stock Holding History

BlackRock Institutional Trust’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$10.5M Buy
2,863,913
+71,593
+3% +$212K ﹤0.01% 2376
2016
Q3 		$9.07M Buy
2,792,320
+110,072
+4% +$308K ﹤0.01% 2388
2016
Q2 		$6.22M Sell
2,682,248
-69,049
-3% -$231K ﹤0.01% 2565
2016
Q1 		$6.88M Buy
2,751,297
+7,684
+0.3% +$17.3K ﹤0.01% 2503
2015
Q4 		$8.42M Buy
2,743,613
+28,274
+1% +$78.9K ﹤0.01% 2440
2015
Q3 		$4.67M Sell
2,715,339
-207,362
-7% -$529K ﹤0.01% 2756
2015
Q2 		$11.9M Sell
2,922,701
-33,918
-1% -$139K ﹤0.01% 2291
2015
Q1 		$11.3M Sell
2,956,619
-5,512
-0.2% -$24K ﹤0.01% 2320
2014
Q4 		$14.2M Sell
2,962,131
-7,577
-0.3% -$30K ﹤0.01% 2132
2014
Q3 		$11M Buy
2,969,708
+100,043
+3% +$338K ﹤0.01% 2263
2014
Q2 		$10.5M Buy
2,869,665
+136,414
+5% +$501K ﹤0.01% 2408
2014
Q1 		$11.5M Buy
2,733,251
+284,123
+12% +$1.41M ﹤0.01% 2327
2013
Q4 		$11.3M Buy
2,449,128
+59,342
+2% +$264K ﹤0.01% 2340
2013
Q3 		$14.8M Sell
2,389,786
-6,725
-0.3% -$38.7K ﹤0.01% 2081
2013
Q2 		$13M Buy
+2,396,511
New +$7.87M ﹤0.01% 2138

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

BlackRock Institutional Trust's IMMU Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Immunomedics Inc (IMMU) stake by 2.6% in Q4 2016, buying an estimated $212K and bringing the position to 2,863,913 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2376.

BlackRock Institutional Trust first reported a position in IMMU in Q2 2013 and has held it in 15 quarters since. The position peaked at $14.8M in Q3 2013. 109 funds tracked by Wall St. Rank hold IMMU as of Q4 2016.

  • BlackRock Institutional Trust held 2,863,913 shares of Immunomedics Inc worth $10.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 71,593 Immunomedics Inc shares in Q4 2016, an estimated $212K.
  • Immunomedics Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2376 holding.
  • BlackRock Institutional Trust first reported a position in Immunomedics Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Immunomedics Inc position peaked at $14.8M in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.